https://prabadinews.com/
  • October 8, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

Trastuzumab Biosimilar Demonstrates Sufficient Efficacy in HER2+ Advanced Gastric Cancer

Trastuzumab Biosimilar Demonstrates Sufficient Efficacy in HER2+ Advanced Gastric Cancer

Herzuma shows promising efficacy and safety as a cost-effective biosimilar for treating HER2+ advanced gastric cancer, offering new hope for patients.

administrator

Related Articles